<PAGE>
                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   FORM 10-QSB


(x)  QUARTERLY  REPORT  UNDER  SECTION  13  OR  15  OF  THE  SECURITIES
      EXCHANGE  ACT  OF  1934

                    For  the  quarterly  period  ended  June  30,  2002
                                                        ---------------

                    Commission  file  number   0-30351
                                               -------


                                TRUE HEALTH, INC.
        (Exact name of small business issuer as specified in its charter)


                  Utah                                75-2263732
       (State  or  other  jurisdiction    (IRS  Employer  Identification  No.)
      of  incorporation or organization)

                     5 Tansey Circle, Mesquite, Texas 75149
                    (Address of principal executive offices)

                                 (972) 644-1200
                          (Issuer's telephone number)

          Securities registered pursuant to Section 12(g) of the Act:
                    Common Stock, Par Value $0.01 Per Share

     Indicate  by  check  mark  whether the Registrant (1) has filed all reports
required  to  be  filed by Section 13 or 15(d) of the Securities Exchange Act of
1934  during  the  preceding  12  months  (or  for  such shorter period that the
registrant  was required to file such reports), and (2) has been subject to such
filing  requirements  for  the  past  90  days.    Yes     X      No______


     As  of  June  30,  2002,  there  were  outstanding 6,471,048 shares of True
Health,  Inc.,  Common  Stock,  par  value  $.01.

Transitional  Small  Business  Disclosure  Format  (Check  one):   Yes  No     x
                                                                   ---  --------

<PAGE>


                                   FORM 10-QSB

                                TRUE HEALTH, INC.
                              Index to Form 10-QSB


                                     PART I



FINANCIAL  INFORMATION  (UNAUDITED)

ITEM  1.     FINANCIAL  STATEMENTS

Balance  Sheets  as  of  June  30,  2002  and  December  31,  2001

Statements  of  Income  (Loss)  for  the Six Months Ended June 30, 2002 and 2001

Statements  of  Income  (Loss)  for  the  Quarters  Ended June 30, 2002 and 2001

Statements  of  Cash  flows  for  the  Six  Months  Ended June 30, 2002 and 2001

Statements  of  Cash  flows  for  the  Quarters  Ended  June  30,  2002 and 2001

Notes  to  Financial  Statements


<PAGE>
                                                               TRUE HEALTH, INC.
                                                                  BALANCE SHEETS
                                 JUNE 30, 2002 (UNAUDITED) AND DECEMBER 31, 2001
--------------------------------------------------------------------------------


<TABLE>
<CAPTION>
                                                                  JUNE 30,
                                                                     2002     DECEMBER 31,
ASSETS                                                          (UNAUDITED)      2001
                                                                ------------  ----------
<S>                                                             <C>               <C>
  Current assets:
    Cash                                                        $       254   $     478
    Accounts receivable, trade                                          209         120
    Inventory                                                        10,846      10,523
                                                                ------------  ----------
      Total current assets                                           11,309      11,121
                                                                ------------  ----------

   Office and computer equipment, net of
      accumulated depreciation of $1,890 and $1,766                     245         369
                                                                ------------  ----------
      Total assets                                              $    11,554   $  11,490
                                                                ============  ==========


LIABILITIES
  Current liabilities:
    Accounts payable and accrued expenses                       $    39,111   $  28,560
    Due to related parties                                           84,676      84,463
                                                                ------------  ----------
      Total current liabilities                                     123,787     113,023
                                                                ------------  ----------

      Total liabilities                                             123,787     113,023
                                                                ------------  ----------

  Commitments and contingencies                                           -           -

STOCKHOLDERS' DEFICIT
  Common stock, $.01 par value, 100,000,000 shares authorized,
     6,471,048 and 6,071,048 shares issued and outstanding           64,710      60,710
  Capital in excess of par value                                    830,009     824,009
  Accumulated deficit                                            (1,006,952)   (986,252)
                                                                ------------  ----------
      Total stockholders' deficit                                  (112,233)   (101,533)
                                                                ------------  ----------
      Total liabilities and stockholders' deficit               $    11,554   $  11,490
                                                                ============  ==========
</TABLE>

The accompanying notes are an integral part of these statements.
<PAGE>
                                                               TRUE HEALTH, INC.
                                     STATEMENTS OF LOSS FOR THE SIX MONTHS ENDED
                                                          JUNE 30, 2002 AND 2001
                                                                    (UNAUDITED)
--------------------------------------------------------------------------------
<TABLE>
<CAPTION>
                                                               2002           2001
                                                          (UNAUDITED)   (UNAUDITED)
                                                          ------------  ------------
<S>                                                           <C>           <C>
Sales                                                     $    12,685   $    17,737
Cost of sales                                                   2,634         3,342
                                                          ------------  ------------
  Gross profit                                                 10,051        14,395
                                                          ------------  ------------

Selling, general, and administrative expenses:
  Salaries and sales commissions                                4,031         5,722
  Research and development                                        335            29
  Depreciation                                                    124           124
  Advertising and promotion                                       218           368
  Professional fees                                            19,408         6,626
  Other                                                         6,635         9,847
                                                          ------------  ------------
    Total selling, general, and administrative expenses        30,751        22,716
                                                          ------------  ------------
    Loss from operations                                      (20,700)       (8,321)
                                                          ------------  ------------

Other income (expense):
  Interest expense                                                  -             -
                                                          ------------  ------------
    Total other income (expense)                                    -             -
                                                          ------------  ------------

Income (loss) before taxes on income                          (20,700)       (8,321)
Provision (credit) for taxes on income                              -             -
                                                          ------------  ------------
    Net income (loss)                                     $   (20,700)  $    (8,321)
                                                          ============  ============


Income (Loss) per common share, basic                     $         -   $         -
                                                          ============  ============
Weighted average number of shares outstanding               6,292,043     6,071,048
                                                          ============  ============
</TABLE>
The accompanying notes are an integral part of these statements.
<PAGE>
                                                               TRUE HEALTH, INC.
                                       STATEMENTS OF LOSS FOR THE QUARTERS ENDED
                                                          JUNE 30, 2002 AND 2001
                                                                     (UNAUDITED)
--------------------------------------------------------------------------------
<TABLE>
<CAPTION>
                                                               2002           2001
                                                          (UNAUDITED)   (UNAUDITED)
                                                          ------------  ------------
<S>                                                            <C>           <C>
Sales                                                     $     6,349   $     7,723
Cost of sales                                                   1,367         1,377
                                                          ------------  ------------
  Gross profit                                                  4,982         6,346
                                                          ------------  ------------

Selling, general, and administrative expenses:
  Salaries and sales commissions                                1,662         2,707
  Research and development                                        274             -
  Depreciation                                                     62            62
  Advertising and promotion                                       132            51
  Professional fees                                            16,828         4,820
  Other                                                         3,421         5,887
                                                          ------------  ------------
    Total selling, general, and administrative expenses        22,379        13,527
                                                          ------------  ------------
    Loss from operations                                      (17,397)       (7,181)
                                                          ------------  ------------

Other income (expense):
  Interest expense                                                  -             -
                                                          ------------  ------------
    Total other income (expense)                                    -             -
                                                          ------------  ------------

Income (loss) before taxes on income                          (17,397)       (7,181)
Provision (credit) for taxes on income                              -             -
                                                          ------------  ------------
    Net income (loss)                                     $   (17,397)  $    (7,181)
                                                          ============  ============


Income (Loss) per common share, basic                     $         -   $         -
                                                          ============  ============
Weighted average number of shares outstanding               6,471,048     6,071,048
                                                          ============  ============

</TABLE>
The accompanying notes are an integral part of these statements.
<PAGE>

                                                               TRUE HEALTH, INC.
                               STATEMENTS OF CASH FLOWS FOR THE SIX MONTHS ENDED
                                                          JUNE 30, 2002 AND 2001
                                                                     (UNAUDITED)
--------------------------------------------------------------------------------

<TABLE>
<CAPTION>
                                                                     2002          2001
                                                               (UNAUDITED)   (UNAUDITED)
                                                               ------------  ------------
<S>                                                                <C>           <C>
Cash flows from operating activities:
   Net income (loss)                                           $   (20,700)  $    (8,321)

  Adjustments to reconcile net income to cash provided (used)
    by operating activities:
      Depreciation                                                     124           124
      Changes in operating assets and liabilities:
        Accounts receivable, trade                                     (89)         (294)
        Inventory                                                     (323)       (2,988)
        Accounts payable and accrued expenses                       10,551         6,262
        Stock issued for services                                   10,000             -
                                                               ------------  ------------
        Net cash flows from by operating activities                   (437)       (5,217)
                                                               ------------  ------------

Cash flows from investing activities:                                    -             -
                                                               ------------  ------------
        Net cash flows from investing activities                         -             -
                                                               ------------  ------------

Cash flows from financing activities:
  Stock issued for services                                         10,000             -
  Less, Amount recognized as operating expenses                    (10,000)            -
  Advances from related parties                                        213         4,809
                                                               ------------  ------------
        Net cash flows from financing activities                       213         4,809
                                                               ------------  ------------

        Net increase (decrease) in cash and cash equivalents          (224)         (408)

Cash and cash equivalents:
  Beginning of period                                                  478         1,280
                                                               ------------  ------------
  End of period                                                $       254   $       872
                                                               ============  ============


Supplemental cash flow disclosures:
  Cash paid for interest                                       $         -   $         -
  Noncash investing and financing activities:
    Stock issued for services                                       10,000             -

</TABLE>
The accompanying notes are an integral part of these statements.

<PAGE>
                                                               TRUE HEALTH, INC.
                                 STATEMENTS OF CASH FLOWS FOR THE QUARTERS ENDED
                                                          JUNE 30, 2002 AND 2001
                                                                     (UNAUDITED)
--------------------------------------------------------------------------------

<TABLE>
<CAPTION>
                                                                   2002        2001
    (UNAUDITED)                                                (UNAUDITED)
                                                               ------------  --------

<S>                                                            <C>           <C>
Cash flows from operating activities:
   Net income (loss)                                           $   (17,397)  $(7,181)

  Adjustments to reconcile net income to cash provided (used)
    by operating activities:
      Depreciation                                                      62        62
      Changes in operating assets and liabilities:
        Accounts receivable, trade                                     (89)     (294)
        Inventory                                                       51      (883)
        Accounts payable and accrued expenses                        6,878     7,363
        Stock issued for services                                   10,000         -
                                                               ------------  --------
        Net cash flows from by operating activities                   (495)     (933)
                                                               ------------  --------

Cash flows from investing activities:                                    -         -
                                                               ------------  --------
        Net cash flows from investing activities                         -         -
                                                               ------------  --------

Cash flows from financing activities:
  Stock issued for services                                              -         -
  Less, Amount recognized as operating expenses                          -         -
  Advances from related parties                                        649     1,226
                                                               ------------  --------
        Net cash flows from financing activities                       649     1,226
                                                               ------------  --------

        Net increase (decrease) in cash and cash equivalents           154       293

Cash and cash equivalents:
  Beginning of period                                                  100       579
                                                               ------------  --------
  End of period                                                $       254   $   872
                                                               ============  ========


Supplemental cash flow disclosures:
  Cash paid for interest                                       $         -   $     -
  Noncash investing and financing activities:
    Stock issued for services                                            -         -

</TABLE>
The accompanying notes are an integral part of these statements.
<PAGE>
                                TRUE HEALTH, INC.
                     NOTES TO UNAUDITED FINANCIAL STATEMENTS

NOTE  1  -  BASIS  OF  PRESENTATION:

The  financial statements include the accounts of True Health, Inc.  The Balance
Sheets as of June 30, 2002 and December 31, 2001, the Statements of Loss for the
six  months  quarters  ended  June 30, 2002 and 2001, and the Statements of Cash
Flows  for  the  six  months and quarters ended June 30, 2002 and 2001 have been
prepared  by  the  Company  without  audit.  In the opinion of management, these
financial  statements  include  all  adjustments necessary to present fairly the
financial position, results of operations and cash flows as of June 30, 2002 and
2001  and for the six months and quarters then ended.  All adjustments made have
been of a normal recurring nature.  Certain information and footnote disclosures
normally  included  in the financial statements prepared in accordance with U.S.
generally  accepted  accounting  principles have been condensed or omitted.  The
Company  believes  that the disclosures included are adequate and provide a fair
presentation  of  interim  period results.  Interim financial statements are not
necessarily  indicative of financial position of operating results for an entire
year.  It  is  suggested  that  these  interim  financial  statements be read in
conjunction with the audited financial statements and the notes thereto included
in the Company's Form 10-KSB for the year ended December 31, 2001 filed with the
United  States  Securities  and  Exchange Commission (SEC) on or about April 15,
2002.

NOTE  2  -  THE  COMPANY,  NATURE  OF  OPERATIONS:

True  Health,  Inc. (the Company) is a Utah corporation engaged in the marketing
of  nutrition  supplement/meal  replacement  products  under the brand name True
Health.  Substantially all of its revenues are derived from these products.  The
products  are  distributed  from  the Company's facilities in Texas to customers
throughout  the world.  The accompanying financial statements have been prepared
on  the  basis  of  U.S.  generally  accepted  accounting  principles.

NOTE  3  -  AGREEMENT  WITH  BURKSHIRE:

In  March, 2002, the Company issued 400,000 shares to stock to Burkshire Capital
Group,  a financial consulting firm, for services in connection with management,
marketing, consulting, strategic planning, corporate organization and structure,
expansion  of  services,  acquisitions and business opportunities, and arranging
equity  financing.  The  consultant was expected to assist the Company in making
private placements of its stock.  The services were valued at $10,000, or $0.025
per  share.  Burkshire's  efforts  were  unsuccessful.  Therefore,  amount  of
$10,000,  which  was  originally recorded as prepaid expenses during the quarter
ended  March  31, 2002, was charged to expense during the quarter ended June 30,
2002.

NOTE  4  -  GOING  CONCERN:

The  Company  has experienced losses in eight of the previous ten years.  Losses
amount to more than $1,000,000 on a cumulative basis.  At June 30, 2002, current
liabilities  exceeded  current  assets by approximately $112,000, resulting in a
working  capital  deficiency;  there  is  also  a  capital  deficit  of the same
approximate amount.  Management is currently investigating alternative marketing
strategies,  methods,  and  markets, and is seeking additional outside financing
and/or  equity investors, but there is no assurance that management's efforts in
this  regard  will  be  successful.  Moreover,  substantially  all  revenues are
derived  from  a single product or line of products, creating a concentration of
business;  should  the Company be unable for any reason to continue sales of the
products,  it  would have a severe impact on the Company's business.  All of the
above  factors  create substantial doubt about the Company's ability to continue
as  a  going  concern.

<PAGE>
ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
OF  OPERATIONS

RESULTS  OF  OPERATIONS

The  Company  had  year-to-date sales of $12,685 for 2002, versus $17,737for the
same  period  of  2001.  During the quarter ended June 30, 2002, sales were down
$1,374  from  the preceding year.  The decrease in sales resulted primarily from
Company  management's  focus  on  raising  additional  equity  capital  and  in
negotiating  agreements  with  a  financial  consulting  firm  (see  below).
Year-to-date  selling, general, and administrative expenses increased to $30,751
from  $22,716, primarily due to consulting fees paid to Burkshire Capital Group.
Year-to-date  net  loss  increased  to $20,700 from $8,321, and the loss for the
quarter  ended  June  30,  2002  increased  to  $17,397  from  $7,181.

The Company had total assets of $11,554 at June 30, 2002, compared to $11,490 at
December  31,  2001,  an  insignificant  change.

In  October  2001,  the Company completed a reverse stock split whereby each ten
(10)  shares  of the Corporation's $0.01 par value common stock outstanding were
converted  into one (1) share of the Corporation's $0.01 par value common stock.
Concurrently  therewith,  the Company's ticker symbol changed from TEHI to TRHH.

In  March, 2002, the Company issued 400,000 shares to stock to Burkshire Capital
Group,  a financial consulting firm, for services in connection with management,
marketing, consulting, strategic planning, corporate organization and structure,
expansion  of  services,  acquisitions and business opportunities, and arranging
equity  financing.  The  consultant was expected to assist the Company in making
private placements of its stock.  The services were valued at $10,000, or $0.025
per  share.  Burkshire's  efforts  were  unsuccessful.  Therefore,  amount  of
$10,000,  which  was  originally recorded as prepaid expenses during the quarter
ended  March  31, 2002, was charged to expense during the quarter ended June 30,
2002.

<PAGE>
                           PART II - OTHER INFORMATION

ITEM  1  -  Legal  Proceedings:

None.

ITEM  2  -  Changes  in  Securities:

In  March, 2002, the Company issued 400,000 shares to stock to Burkshire Capital
Group,  a financial consulting firm, for services in connection with management,
marketing, consulting, strategic planning, corporate organization and structure,
expansion  of  services,  acquisitions and business opportunities, and arranging
equity  financing.  The  consultant was expected to assist the Company in making
private placements of its stock.  The services were valued at $10,000, or $0.025
per  share.  Burkshire's  efforts  were  unsuccessful.  Therefore,  amount  of
$10,000,  which  was  originally recorded as prepaid expenses during the quarter
ended  March  31, 2002, was charged to expense during the quarter ended June 30,
2002.


ITEM  3  -  Defaults  Upon  Senior  Securities:

None.

ITEM  4  -  Submission  of  Matters  to  a  Vote  of  Security  Holders:

The  Company  had  an annual shareholders meeting on August 1, 2001.  A slate of
officers  was  elected for the next year and a reverse stock split was approved.

ITEM  5  -  Other  Information:

 This  form  10-QSB  includes  or may include certain forward-looking statements
concerning  the  Company's  financial  position,  business  strategy,  budgets,
projected  costs and plans and objectives of management for future operations as
well  as  other  statements  including  words  such  as "anticipate," "believe,"
"plan," "estimate," "expect," "intend," and other similar expressions.  Although
the  Company  believes  its  expectations  reflected  in  such  forward-looking
statements  are  based  on reasonable assumptions, readers are cautioned that no
assurance can be given that such expectations will prove correct and that actual
results  and  developments  may  differ  materially  from those conveyed in such
forward-looking  statements.  Important  factors that could cause actual results
to  differ  materially  from  the  expectations reflected in the forward-looking
statements  in  the  Form 10-SB include, among others, the pace of technological
change,  the  Company's  ability to manage growth, general business and economic
conditions  in  the  Company's  operating  regions,  and  competitive  and other
factors,  all  as more fully described in the Company's Report on Form 10-SB for
the  period  ended December 31, 2001, under Management's Discussion and Analysis
of  Financial  Condition  and  Results  of  Operations.  "Assumptions Underlying
Certain  Forward-Looking  Statements and Factors that May Affect Future Results"
and  elsewhere  from  time  to  time  in  the Company's other SEC reports.  Such
forward-looking  statements speak only as of the date on which they are made and
the  Company  does  not  undertake  any obligation to update any forward-looking
statement to reflect events or circumstances after the date of this Form 10-QSB.
If  the  Company  does update or correct one or more forward-looking statements,
investors  and others should not conclude that the Company would make additional
updates  or  corrections  with  respect  thereto  or  with  respect  to  other
forward-looking  statements.  Actual  results  may  vary  materially.

ITEM  6.  Exhibits  And  Reports  On  Form  8-K:

None.
<PAGE>

                                   SIGNATURES

Pursuant  to  the requirements of Section 13 or 15(d) of the Securities Exchange
Act  of  1934,  the  Registrant  has duly caused this report to be signed on its
behalf  by  the  undersigned,  thereunto  duly  authorized.


                                        TRUE  HEALTH,  INC.
                                        -------------------
                                        (Registrant)


    Date: _________________    By:___________________________________________
                                        (Signature)
                                        Richard  M.  Stokley
                                        President





<PAGE>